Table 1 Number of subjects diagnosed with non-gout crystal arthropathy (ICD10 M11) and relative distributions of subtypes for both prevalent cases (N = 2393) and incident cases (N = 2017) in 2014. Only the first (incident) diagnosis for 217 incident cases is listed. Diagnosis among (prevalent) cases-only the latest diagnosis included one diagnosis per person
From: Prevalence and incidence of non-gout crystal arthropathy in southern Sweden
IC10 diagnostic codes | The numbers and distribution of subjects diagnosed with the various subcodes within M11 group among prevalent cases number (%) | The numbers and distribution of subjects diagnosed with the various subcodes within M11 group among incident cases number (%) | |
|---|---|---|---|
All non-gout crystal arthropathies | 2393 (100%) | 217 (100%) | |
Calcium pyrophosphate crystal deposition related arthropathy | M11.8 calcium pyrophosphate arthropathy | 216 (9.03%) | 26 (8.13%) |
M11.8B in shoulder joint | 9 (0.38%) | 2 (0.63%) | |
M11.8C in elbow joint | 14 (0.59%) | 3 (0.94%) | |
M11.8D in wrist joint/hand | 61 (2.55%) | 20 (6.25%) | |
M11.8F in hip joint | 11 (0.46%) | 2 (0.63%) | |
M11.8G in knee joint | 352 (14.71%) | 48 (15.0%) | |
M11.8H in ankle and foot | 31 (1.30%) | 7 (2.19%) | |
M11.8X site unspecified | 12 (0.5%) | 10 (3.13%) | |
Chondrocalcinosis | M11.1 familial chondrocalcinosis | 7 (0.29%) | 0 |
M11.2 other chondrocalcinosis | 68 (2.84%) | 3 (0.94%) | |
Hydroxyapatite crystal deposition disease | M11.0 hydroxyapatite deposition disease | 22 (0.92%) | 5 (1.56%) |
Unspecified other non-gout arthropathies | M11.9 crystal arthropathy, unspecified | 289 (12.08%) | 36 (11.25%) |
M11.9B crystal arthropathy, unspecified in shoulder joint | 23 (0.96%) | 2 (0.63%) | |
M11.9C crystal arthropathy, unspecified in elbow joint | 18 (0.75%) | 5 (1.56%) | |
M11.9D Crystal arthropathy, unspecified in wrist joint/ hand | 120 (5.01%) | 20 (6.25%) | |
M11.9F crystal arthropathy, unspecified in hip joint | 33 (1.38%) | 2 (0.63%) | |
M11.9G crystal arthropathy, unspecified in knee joint | 434 (18.14%) | 37 (11.56%) | |
M11.9H crystal arthropathy, unspecified in ankle and foot | 199 (8.32%) | 12 (3.75%) | |
M11.9X crystal arthropathy, unspecified with unspecified site | 9 (0.38%) | 5 (1.56%) | |
M11- other crystal arthritis, unspecified | 465 (19.43%) | 75 (23.4%) |